New perspectives on how to discover drugs from herbal medicines: CAM'S outstanding contribution to modern therapeutics

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Pan, Si Yuan ^a   Zhou, Shu Feng ^b   Gao, Si Hua ^a   Yu, Zhi Ling ^c   Zhang, Shuo Feng ^a   Tang, Min Ke ^a   Sun, Jian Ning ^a   Ma, Dik Lung ^c   Han, Yi Fan ^d   Fong, Wang Fun ^c   Ko, Kam Ming ^e  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^d HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; ARTEMETHER; ARTESUNATE; CHINESE DRUG; DIHYDROARTEMISININ; HERBACEOUS AGENT; LIVER PROTECTIVE AGENT;

ARTICLE; CHINESE MEDICINE; DATA BASE; DRUG BIOAVAILABILITY; HERBAL MEDICINE; HUMAN; KNOWLEDGE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; TRADITIONAL MEDICINE;

EID: 84876532392     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/627375     Document Type: Article

References (239)

1. Wu M., Atchley D., Greer L., Janssen S., Rosenberg D., Sass J., Dosed without prescription: preventing pharmaceutical contamination of our nation's drinking water. http://docs.nrdc.org/health/files/hea-10012001a.pdf
2. Barden C. J., Weaver D. F., The rise of micropharma. Drug Discovery Today 2010 15 3-4 84 87 2-s2.0-75149144934 10.1016/j.drudis.2009.10.001
3. Graul A. I., Revel L., Barrionuevo M., The year's new drugs & biologics-2008. Drug News and Perspectives 2009 22 1 7 29
4. Kuhne S., The future science, buisness and innovation. http://www.sciencebus.se/Sciencebus/SebastiaanKuhne-files/SEBASTIAAN%20KUHNE.pdf
5. Sibbald B., Rofecoxib (Vioxx) voluntarily withdrawn from market. Canadian Medical Association Journal 2004 171 9 1027 1028 2-s2.0-11244249628
6. Pan S. Y., Gao S. H., Zhou S. F., New perspectives on complementary and alternative medicine: an overview and alternative therapy. Alternative Therapies in Health and Medicine 2012 18 4 20 36
7. Winslow L. C., Kroll D. J., Herbs as medicines. Archives of Internal Medicine 1998 158 20 2192 2199 2-s2.0-0032501113 10.1001/archinte.158.20.2192 (Pubitemid 28512493)
8. Raman R., Kandula S., Zoopharmacognosy. http://www.ias.ac.in/resonance/ March2008/p245-253.pdf
9. Krief S., Jamart A., Mahé S., Leendertz F. H., Mätz-rensing K., Crespeau F., Bain O., Guillot J., Clinical and pathologic manifestation of oesophagostomosis in African great apes: does self-medication in wild apes influence disease progression? Journal of Medical Primatology 2008 37 4 188 195 2-s2.0-48649086159 10.1111/j.1600-0684.2008.00285.x
10. Fowler A., Koutsioni Y., Sommer V., Leaf-swallowing in Nigerian chimpanzees: evidence for assumed self-medication. Primates 2007 48 1 73 76 2-s2.0-33845542870 10.1007/s10329-006-0001-6 (Pubitemid 44921600)
11. Pan S. Y., Chen S. B., Dong H. G., New perspectives on Chinese herbal medicine (Zhong-Yao) research and development. Evidence Based Complementary and Alternative Medicine 2011 2011 11 403709 10.1093/ecam/neq056
12. He S. M., Chan E., Zhou S. F., ADME properties of herbal medicines in humans: evidence, challenges andstrategies. Current Pharmaceutical Design 2011 17 4 357 407 2-s2.0-79958290393 10.2174/138161211795164194
13. Chan E., Tan M., Xin J., Sudarsanam S., Johnson D. E., Interactions between traditional Chinese medicines and Western therapeutics. Current Opinion in Drug Discovery and Development 2010 13 1 50 65 2-s2.0-73849123558
14. Chen X. W., Sneed K. B., Pan S. Y., Herb-drug interactions and mechanistic and clinical considerations. Current Medicinal Chemistry 2012 13 5 640 651
15. Chen X. W., Serag E. S., Sneed K. B., Clinical herbal interactions with conventional drugs: from molecules to maladies. Current Medicinal Chemistry 2011 18 31 4836 4850 10.2174/092986711797535317
16. Patwardhan B., Vaidya A. D. B., Chorghade M., Ayurveda and natural products drug discovery. Current Science 2004 86 6 789 799 2-s2.0-3442902875 (Pubitemid 39169379)
17. Gordaliza M., Terpenyl-purines from the sea. Marine Drugs 2009 7 4 833 849 2-s2.0-75149155218 10.3390/md7040833
18. Maridass M., John de Britto A., Origins of plant derived medicines. Ethnobotanical Leaflets 2008 12 373 387
19. Krief S., Martin M. T., Grellier P., Kasenene J., Sévenet T., Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda. Antimicrobial Agents and Chemotherapy 2004 48 8 3196 3199 2-s2.0-3342899897 10.1128/AAC.48.8.3196-3199.2004 (Pubitemid 38989204)
20. Samy R. P., Pushparaj P. N., Gopalakrishnakone P., A compilation of bioactive compounds from Ayurveda. Bioinformation 2008 3 3 100 110 10.6026/97320630003100
21. Farnsworth N. R., Screening plants for new medicines. http://www.ciesin.org/docs/002-256c/002-256c.html
22. Yirga G., Teferi M., Kasaye M., Survey of medicinal plants used to treat human ailments in Hawzen district, Northern Ethiopia. International Journal of Biodiversity and Conservation 2011 3 13 709 714
23. Cameron S. I., Smith R. F., Kierstead K. E., Linking medicinal/ nutraceutical products research with commercialization. Pharmacetical Biology 2005 43 5 425 433 10.1080/13880200590963736 (Pubitemid 41291325)
24. Deng Z. L., Application of new techniques in the innovative research of Chinese herbal medicine Chinese Pharmaceutical 2007 16 58 589
25. Sithranga Boopathy N., Kathiresan K., Anticancer drugs from marine flora: an overview. Journal of Oncology 2010 2010 18 214186 10. 1155/2010/214186
26. Boopathy N. S., Kathiresan K., Anticancer drugs from marine flora: an overview. Journal of Oncology 2010 2010 18 214186 10.1155/2010/214186
27. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 2007 70 3 461 477 2-s2.0-34247109045 10.1021/np068054v (Pubitemid 46595760)
28. Poupko J. M., Baskin S. I., Moore E., The pharmacological properties of anisodamine. Journal of Applied Toxicology 2007 27 2 116 121 2-s2.0-33947581846 10.1002/jat.1154 (Pubitemid 46480578)
29. Eisenbrand G., Hippe F., Jakobs S., Muehlbeyer S., Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. Journal of Cancer Research and Clinical Oncology 2004 130 11 627 635 2-s2.0-8644224855 10.1007/s00432-004-0579-2 (Pubitemid 39506375)
30. Desilets A. R., Gickas J. J., Dunican K. C., Role of huperzine A in the treatment of alzheimer's disease. Annals of Pharmacotherapy 2009 43 3 514 518 2-s2.0-62949139899 10.1345/aph.1L402
31. Xiang D. R., Sheng J. F., The analyse of effectiveness in HBeAg-positive chronic viral hepatitis B treated by adefovir dipivoxil combined with bicyclol. Chinese Journal of Experimental and Clinical Virology 2009 23 4 299 301 2-s2.0-77449110151
32. Zhu X. Z., Li X. Y., Liu J., Recent pharmacological studies on natural products in China. European Journal of Pharmacology 2004 500 1-3 221 230 2-s2.0-4644238761 10.1016/j.ejphar.2004.07.027 (Pubitemid 39304010)
33. Kuo C. L., Chi C. W., Liu T. Y., The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Letters 2004 203 2 127 137 2-s2.0-0346724714 10.1016/j.canlet.2003.09.002 (Pubitemid 38063132)
34. Yan D., Jin C., Xiao X. H., Dong X. P., Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. Journal of Biochemical and Biophysical Methods 2008 70 6 845 849 2-s2.0-48649105820 10.1016/j.jbbm.2007.07.009
35. Vuddanda P. R., Chakraborty S., Singh S., Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opinion on Investigational Drugs 2010 19 10 1297 1307 2-s2.0-77956589652 10.1517/13543784.2010.517745
36. Walsh V., Goodman J., Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol. Social Science and Medicine 1999 49 9 1215 1225 2-s2.0-0033231777 10.1016/S0277-9536(99)00161-6 (Pubitemid 29395549)
37. Khachik F., Steck A., Pfander H., Isolation and structural elucidation of (13Z,13'Z,3R,3'R,6'R)-lutein from marigold flowers, kale, and human plasma. Journal of Agricultural and Food Chemistry 1999 47 2 455 461 2-s2.0-0032968378 10.1021/jf980823w (Pubitemid 29185208)
38. Lippi G., Targher G., Tomatoes, lycopene-containing foods and cancer risk. British Journal of Cancer 2011 104 7 1234 1235 2-s2.0-79953170490 10.1038/bjc.2011.59
39. Sasidharan S., Chen Y., Saravanan D., Sundram K. M., Yoga Latha L., Extraction, isolation and characterization of bioactive compounds from plants' extracts. African Journal of Traditional, Complementary, and Alternative Medicines 2011 8 1 1 10
40. Ramberg J. E., Nelson E. D., Sinnott R. A., Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutrition Journal 2010 9, article 54 10.1186/1475-2891-9-54
41. Xu Z., Chen X., Zhong Z., Chen L., Wang Y., Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. The American Journal of Chinese Medicine 2011 39 1 15 27 2-s2.0-78751493724 10.1142/S0192415X11008610
42. Holderness J., Schepetkin I. A., Freedman B., Kirpotina L. N., Quinn M. T., Hedges J. F., Jutila M. A., Polysaccharides isolated from açaí fruit induce innate immune responses. PLoS One 2011 6 2 2-s2.0-79952220336 10.1371/journal.pone.0017301 e17301
43. Leonarduzzi G., Testa G., Sottero B., Gamba P., Poli G., Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Current Medicinal Chemistry 2010 17 1 74 95 2-s2.0-77249122561 10.2174/092986710789957760
44. Im A. R., Kim Y. H., Uddin M. R., Scutellaria baicalensis extracts and flavonoids protect rat L6 cells from antimycin A-induced mitochondrial dysfunction. Evidence Based Complementary and Alternative Medicine 2012 2012 8 517965 10. 1155/2012/517965. 2012
45. Procházková D., Boušová I., Wilhelmová N., Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011 82 4 513 523 10.1016/j.fitote.2011.01.018
46. Jäger A. K., Saaby L., Flavonoids and the CNS. Molecules 2011 16 2 1471 1485 10.3390/molecules16021471
47. Sheng J. P., Chen H. R., Shen L., Comparative study on selenium and amino acids content in leaves of planted and wild scutellaria baicalensis Spectroscopy and Spectral Analysis 2009 29 1 211 213 2-s2.0-59649099137
48. Dai J., Mumper R. J., Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 2010 15 10 7313 7352 2-s2.0-78149448327 10.3390/molecules15107313
49. Sinha A. K., Sharma U. K., Sharma N., A comprehensive review on vanilla flavor: extraction, isolation and quantification of vanillin and others constituents. International Journal of Food Sciences and Nutrition 2008 59 4 299 326 2-s2.0-42649096954 10.1080/09687630701539350 (Pubitemid 351596031)
50. Sahraoui N., Vian M. A., Bornard I., Boutekedjiret C., Chemat F., Improved microwave steam distillation apparatus for isolation of essential oils. Comparison with conventional steam distillation. Journal of Chromatography A 2008 1210 2 229 233 2-s2.0-54249168304 10.1016/j.chroma.2008.09.078
51. Li F., Zhang Z., Sun X., Wang W., Ma M., Optimization of extraction conditions for semi-bionic extraction of Guizhi Fuling pill decoction by uniform design Journal of Chinese Materia Medica 2010 35 16 2151 2156 2-s2.0-78649912527 10.4268/cjcmm20101626
52. He Z., Xia W., Microwave-assisted extraction of phenolics from Canarium album L. and identification of the main phenolic compound. Natural Product Research 2011 25 2 85 92 2-s2.0-78951484233 10.1080/14786410701592778
53. Lesellier E., Supercritical fluid chromatography for bioanalysis: practical and theoretical considerations. Bioanalysis 2011 3 2 125 131 2-s2.0-79951920685 10.4155/bio.10.188
54. Guo C. X., Wang S. K., Applications of the art technology in separations of effective components of natural products Chemistry and Bioengineering 2006 23 5 38 40
55. Extracts of Chinese herbal medicine. http://baike.baidu.com/view/108090. htm
56. Martens S., Mithöfer A., Flavones and flavone synthases. Phytochemistry 2005 66 20 2399 2407 2-s2.0-26444611245 10.1016/j.phytochem.2005. 07.013 (Pubitemid 41427764)
57. Alkaloids. http://www.zhong-yao.net/zy/gy/hx/200803/106966.html
58. Lee M. R., The history of Ephedra (ma-huang). The Journal of the Royal College of Physicians of Edinburgh 2011 41 1 78 84 2-s2.0-79959512168 10.4997/JRCPE.2011.116
59. de Quattro V., Li D., Sympatholytic therapy in primary hypertension: a user friendly role for the future. Journal of Human Hypertension 2002 16 supplement 1 S118 S123 2-s2.0-0036232022 10.1038/sj/jhh/1001356 (Pubitemid 34441147)
60. Lima J. P. S. N., dos Santos L. V., Sasse E. C., Lima C. S. P., Sasse A. D., Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. Journal of Thoracic Oncology 2010 5 12 1986 1993 2-s2.0-78650513543 10.1097/JTO.0b013e3181f2451c
61. Glade R. S., Vinson K., Becton D., Bhutta S., Buckmiller L. M., Management of complicated hemangiomas with vincristine/vinblastine: quantitative response to therapy using MRI. International Journal of Pediatric Otorhinolaryngology 2010 74 11 1221 1225 2-s2.0-77957731089 10.1016/j.ijporl. 2010.07.014
62. Gupta D., Bleakley B., Gupta R. K., Dragon's blood: botany, chemistry and therapeutic uses. Journal of Ethnopharmacology 2008 115 3 361 380 2-s2.0-37549000584 10.1016/j.jep.2007.10.018 (Pubitemid 50017507)
63. Chan E. C. Y., Yap S. L., Lau A. J., Leow P. C., Toh D. F., Koh H. L., Ultra-performance liquid chromatography/time-of-flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng. Rapid Communications in Mass Spectrometry 2007 21 4 519 528 2-s2.0-33847126285 10.1002/rcm.2864 (Pubitemid 46294300)
64. Liu G. Y., Li X. W., Wang N. B., Zhou H. Y., Wei W., Gui M. Y., Yang B., Jin Y. R., Three new dammarane-type triterpene saponins from the leaves of Panax ginseng C.A. Meyer. Journal of Asian Natural Products Research 2010 12 10 865 873 2-s2.0-77957901397 10.1080/10286020.2010.508035
65. Wang H., Peng D., Xie J., Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chinese Medicine 2009 4, article 20 2-s2.0-70450278777 10.1186/1749-8546-4-20
66. Medicinal plants,. http://www.ggssc.net/files/pdf/medicinal-plants.PDF
67. State food and drug administration. http://app1.sfda.gov.cn/datasearch/ face3/dir.html
68. Leung's (Chinese) herb news. http://www.phyto-tech.com/lchn/1997-06.html
69. US pharmaceutical industry report, 2008-2009. http://big5.askci.com/http: //www.askci.com/enreports/2009-04/2009430113842.html
70. Strategic adjustment of multinational pharmaceutical companies. http://www.istis.sh.cn/list/list.aspx?id=1787
71. Valant C., Robert Lane J., Sexton P. M., Christopoulos A., The best of both worlds? Bitopic orthosteric/allosteric ligands of G protein-coupled receptors. Annual Review of Pharmacology and Toxicology 2012 52 153 178 10.1146/annurev-pharmtox-010611-134514
72. Fang L., Jumpertz S., Zhang Y., Appenroth D., Fleck C., Mohr K., Tränkle C., Decker M., Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors. Journal of Medicinal Chemistry 2010 53 5 2094 2103 2-s2.0-77949343551 10.1021/jm901616h
73. Zheng X. H., Zhang Y. C., Zhang Q. Z., Zhao X. F., Synthesis and usage of Tanshinol borneol ester. Patent no. ZL20060042787.3
74. Li W. M., Kan K. K. W., Carlier P. R., Pang Y. P., Han Y. F., East meets west in the search for Alzheimer's therapeutics-novel dimeric inhibitors from tacrine and huperzine A. Current Alzheimer Research 2007 4 4 386 396 2-s2.0-34548687019 10.2174/156720507781788918 (Pubitemid 47416631)
75. Itoh Y., Ishikawa M., Naito M., Hashimoto Y., Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins. Journal of the American Chemical Society 2010 132 16 5820 5826 2-s2.0-77952565704 10.1021/ja100691p
76. Decker M., Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. Current Medicinal Chemistry 2011 18 10 1464 1475 2-s2.0-79955028274 10.2174/092986711795328355
77. Setyawan A. D., Traditionally utilization of Selaginella, field research and literature review. Bioscience 2009 1 3 146 158
78. Muregi F. W., Ishih A., Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Development Research 2010 71 1 20 32 2-s2.0-76749095030 10.1002/ddr.20345
79. O'Neill P. M., Barton V. E., Ward S. A., The molecular mechanism of action of artemisininthe debate continues. Molecules 2010 15 3 1705 1721 10.3390/molecules15031705
80. Roll Back Malaria Partners set ambitious financial targets for 19 African countries fighting malaria. http://www.rollbackmalaria.org/amd2007/pr/pr- rbmAMD2007-e.pdf
81. Malaria: severe, life-threatening. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2943816/pdf/2007-0913.pdf
82. Idro R., Marsh K., John C. C., Newton C. R. J., Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric Research 2010 68 4 267 274 2-s2.0-77957288323 10.1203/PDR. 0b013e3181eee738
83. Hsu E., The history of qing hao in the Chinese materia medica. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006 100 6 505 508 2-s2.0-33645877368 10.1016/j.trstmh.2005.09.020
84. Qing Hao. http://www.hudong.com/wiki/%E9%9D%92%E8%92%BF
85. Brown G. D., The biosynthesis of artemisinin (Qinghaosu) and the phytochemistry of artemisia annua L. (Qinghao). Molecules 2010 15 11 7603 7698 2-s2.0-78649475176 10.3390/molecules15117603
86. Webster H. K., Lehnert E. K., Chemistry of artemisinin: an overview. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994 88 supplement 1 S27 S29 2-s2.0-0028290375 (Pubitemid 24206482)
87. Balint G. A., Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacology and Therapeutics 2001 90 2-3 261 265 2-s2.0-0034813570 10.1016/S0163-7258(01)00140-1 (Pubitemid 32913479)
88. Kumar V., Mahajan A., Chibale K., Synthetic medicinal chemistry of selected antimalarial natural products. Bioorganic and Medicinal Chemistry 2009 17 6 2236 2275 2-s2.0-62149083415 10.1016/j.bmc.2008.10.072
89. Griesbeck A. G., Neudörfl J., Hörauf A., Specht S., Raabe A., Antimalarial peroxide dyads from natural artemisinin and hydroxyalkylated 1,2,4-trioxanes. Journal of Medicinal Chemistry 2009 52 10 3420 3423 2-s2.0-66249100853 10.1021/jm9002523
90. Li Y., Wu Y. L., How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives? Médecine Tropicale 1998 58 supplement 3 S9 S12
91. Klayman D. L., Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985 228 4703 1049 1055 2-s2.0-0021948029 (Pubitemid 15227365)
92. Shen D. D., Zang Y. X., Shen M. M., Yang X. C., Ha C. Y., Progress in dihydroartemisinin derivatives. http://wenku.baidu.com/view/ 2e5468c6aa00b52acfc7ca98.html
93. El-Feraly F. S., Al-Yahya M. A., Orabi K. Y., McPhail D. R., McPhail A. T., A new method for the preparation of arteether and its C-9 epimer. Journal of Natural Products 1992 55 7 878 883 2-s2.0-0026717204
94. Ramharter M., Burkhardt D., Nemeth J., Adegnika A. A., Kremsner P. G., Short report: in vitro activity of artemisone compared with artesunate against Plasmodium falciparum. The American Journal of Tropical Medicine and Hygiene 2006 75 4 637 639 2-s2.0-33750611822 (Pubitemid 46941267)
95. O'Neill P. M., The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents. Expert Opinion on Investigational Drugs 2005 14 9 1117 1128 2-s2.0-24344443742 10.1517/13543784.14.9.1117 (Pubitemid 41246167)
96. Lombard M. C., N'Da D. D., Breytenbach J. C., Smith P. J., Lategan C. A., Artemisinin-quinoline hybrid-dimers: synthesis and in vitro antiplasmodial activity. Bioorganic and Medicinal Chemistry Letters 2010 20 23 6975 6977 2-s2.0-78149409939 10.1016/j.bmcl.2010.09.130
97. Lee S., Artemisinin, promising lead natural product for various drug developments. Mini-Reviews in Medicinal Chemistry 2007 7 4 411 422 2-s2.0-34247618370 10.2174/138955707780363837 (Pubitemid 46681763)
98. Lu F. M., Zhuang H., Management of hepatitis B in China. Chinese Medical Journal 2009 122 1 3 4 2-s2.0-60649105085 10.3760/cma.j.issn.0366-6999.2009.01. 001
99. Hepatitis,. http://www.mahalo.com/hepatitis/
100. Lu F. M., Zhuang H., Management of hepatitis B in China. Chinese Medicine Journal 2009 122 1 3 4
101. Anti-hepatitis new drug bicyclol. http://www.5ymy.com/news/gxytj/0931383. html
102. Panossian A., Wikman G., Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 2008 118 2 183 212 2-s2.0-45449105337 10.1016/j.jep.2008.04.020
103. Lu Y., Chen D. F., Analysis of Schisandra chinensis and Schisandra sphenanthera. Journal of Chromatography A 2009 1216 11 1980 1990 2-s2.0-60349120689 10.1016/j.chroma.2008.09.070
104. Xie W., Du L., Diabetes is an inflammatory disease: evidence from traditional Chinese medicines Diabetes, Obesity and Metabolism 2011 13 4 289 301 2-s2.0-79951931336 10.1111/j.1463-1326.2010.01336.x
105. Pao T. T., Liu K. T., Hsu H. F., Sung C. Y., Studies on Fructus schizandrae. I. Its effect on increased SGPT levels in animals caused by hepatotoxic chemical agents Journal of Chinese Medicine 1974 5 2 275 278 2-s2.0-0016063204
106. Chen Y. Y., Shu Z. B., Li L. N., Schisandra study-isolation and identification of bioactive ingredients for lowering alanine aminotransferase activity Science China A 1976 1 98 110
107. Chen Y. Y., Li L. N., Schisandra study-determination of schizander A and B structure Acta Chimica Sinica 1976 34 48 55
108. Bao T. T., Tu G. F., Liu G. T., Sun R. H., Song Z. Y., A comparison of the pharmacological actions of seven constituents isolated from fructus schizadrae (author's transl) Acta Pharmaceutica Sinica 1979 14 1 1 7 2-s2.0-0003142960
109. Xie J. X., Zhou J., Zhan Z., Yang J. H., Chen J. X., Jin H. Q., Synthesis of schizandrin C analogs Acta Pharmacologica Sinica 1981 16 4 306 309
110. Liu G. T., Wei H. L., Song Z. Y., Further studies on the protective action of biphenyl dimethyl-dicarboxylate (BDD) against experimental liver injury in mice (author's transl). Acta Pharmaceutica Sinica 1982 17 2 101 106 2-s2.0-0008437793
111. Liu G. T., From the study of Fructus schizandrae to the discovery of biphenyl dimethyl-dicarboxylate. Acta Pharmaceutica Sinica 1983 18 9 714 720 2-s2.0-0344194622
112. Wang X. L., Yi M. G., Liu Z. M., Song Z. Y., Absorption, distribution and excretion of biphenyl dimethyl-dicarboxylate (BDD). Acta Pharmaceutica Sinica 1983 18 12 892 899 2-s2.0-0020912404
113. Liu G. T., The anti virus and hepatoprotective effect of bicyclol and its mechanism of action Chinese Journal of New Drugs 2001 10 5 325 327
114. Gu X. J., The efficacy of bicyclol in treatment of chronic hepatitis B. Chin. Chinese Journal of New Drugs 2004 13 10 940 942
115. Li Y., Dai G. W., Liu G. T., Li Y., Effect of bicyclol on acetaminophen-induced hepatotoxicity: energetic metabolism and mitochondrial injury in acetaminophen-intoxicated mice Acta Pharmacologica Sinica 2001 36 10 723 726 2-s2.0-0001012455 (Pubitemid 33629811)
116. Hu W., Zhang C. Z., Li Y., Resolution of racemic anti-hepatitis drug (+/-) -bicyclol Acta Pharmacologica Sinica 2006 41 3 221 224 (Pubitemid 43690890)
117. Tang Y., Hu W., Li Y., Zhang C. Z., Synthesis of metabolites of bicyclol Acta Pharmacologica Sinica 2007 42 10 1054 1057
118. Pan S. Y., Dong H., Guo B. F., Zhang Y., Yu Z. L., Fong W. F., Han Y. F., Ko K. M., Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate. Naunyn-Schmiedeberg's Archives of Pharmacology 2011 383 6 585 591 2-s2.0-79959373980 10.1007/s00210-011-0634-x
119. Pan S. Y., Yu Z. L., Dong H., Xiang C. J., Fong W. F., Ko K. M., Ethanol extract of fructus schisandrae decreases hepatic triglyceride level in mice fed with a high fat/cholesterol diet, with attention to acute toxicity. Evidence-based Complementary and Alternative Medicine 2011 2011 6 2-s2.0-79952145519 10.1093/ecam/nep070 729412
120. Pan S. Y., Dong H., Zhao X. Y., Xiang C. J., Fang H. Y., Fong W. F., Yu Z. L., Ko K. M., Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice. The Journal of Pharmacy and Pharmacology 2008 60 3 399 403 2-s2.0-39449088904 10.1211/jpp.60.3.0017 (Pubitemid 351269829)
121. Pan S. Y., Dong H., Yu Z. L., Zhao X. Y., Xiang C. J., Wang H., Fong W. F., Ko K. M., Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. The Journal of Pharmacy and Pharmacology 2007 59 12 1657 1662 2-s2.0-36849043037 10.1211/jpp.59.12.0007 (Pubitemid 350221810)
122. Pan S. Y., Yang R., Dong H., Yu Z. L., Ko K. M., Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. European Journal of Pharmacology 2006 552 1-3 170 175 2-s2.0-33750471637 10.1016/j.ejphar.2006.09.011 (Pubitemid 44648081)
123. Pan S. Y., Yang R., Han Y. F., Dong H., Feng X. D., Li N., Geng W., Ko K. M., High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia. Acta Pharmacologica Sinica 2006 27 6 673 678 2-s2.0-33745414014 10.1111/j.1745-7254. 2006.00332.x (Pubitemid 43943914)
124. Pan S. Y., Dong H., Han Y. F., Li W. Y., Zhao X. Y., Ko K. M., A novel experimental model of acute hypertriglyceridemia induced by schisandrin B. European Journal of Pharmacology 2006 537 1-3 200 204 2-s2.0-33646162647 10.1016/j.ejphar.2006.03.001
125. Pan S. Y., Yu Q., Zhang Y, Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids in Health and Disease 2012 11, article 120 10.1186/1476-511X-11-120
126. Chu J. H., Wang H., Ye Y., Chan P. K., Pan S. Y., Fong W. F., Yu Z. L., Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. World Journal of Gastroenterology 2011 17 19 2379 2388 2-s2.0-79957845984 10.3748/wjg.v17.i19.2379
127. Berger S. I., Iyengar R., Network analyses in systems pharmacology. Bioinformatics 2009 25 19 2466 2472 2-s2.0-70349847876 10.1093/bioinformatics/ btp465
128. Boran A. D. W., Iyengar R., Systems pharmacology. Mount Sinai Journal of Medicine 2010 77 4 333 344 2-s2.0-77955007370 10.1002/msj.20191
129. Ericson E., Gebbia M., Heisler L. E., Wildenhain J., Tyers M., Giaever G., Nislow C., Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genetics 2008 4 8 2-s2.0-50849097234 10.1371/journal.pgen. 1000151 e1000151
130. Wang Y., Bolton E., Dracheva S., Karapetyan K., Shoemaker B. A., Suzek T. O., Wang J., Xiao J., Zhang J., Bryant S. H., An overview of the PubChem BioAssay resource. Nucleic Acids Research 2009 38 1 D255 D266 2-s2.0-75549087817 10.1093/nar/gkp965 gkp965
131. Wang Y., Xiao J., Suzek T. O., Zhang J., Wang J., Bryant S. H., PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Research 2009 37 2 W623 W633 2-s2.0-67849104638 10.1093/nar/gkp456
132. PDTD [Potential Drug Target Database],. http://www.dddc.ac.cn/pdtd/
133. Gao Z., Li H., Zhang H., Liu X., Kang L., Luo X., Zhu W., Chen K., Wang X., Jiang H., PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008 9, article 104 2-s2.0-40549130652 10.1186/1471-2105-9-104 (Pubitemid 351356783)
134. PDB,. http://www.rcsb.org/pdb/
135. Berman H. M., Westbrook J., Feng Z., The protein data bank. Nucleic Acids Research 2000 28 1 235 242 10.1093/nar/28.1.235 (Pubitemid 30047768)
136. Drews J., Drug discovery: a historical perspective. Science 2000 287 5460 1960 1964 2-s2.0-0034677966 10.1126/science.287.5460.1960 (Pubitemid 30158662)
137. Leader B., Baca Q. J., Golan D. E., Protein therapeutics: a summary and pharmacological classification. Nature Reviews Drug Discovery 2008 7 1 21 39 2-s2.0-37749004225 10.1038/nrd2399
138. Hopkins A. L., Groom C. R., The druggable genome. Nature Reviews Drug Discovery 2002 1 9 727 730 2-s2.0-0036717194 (Pubitemid 37361545)
139. Li Q., Cheng T., Wang Y., Bryant S. H., PubChem as a public resource for drug discovery. Drug Discovery Today 2010 15 23-24 1052 1057 2-s2.0-78649633211 10.1016/j.drudis.2010.10.003
140. Sunset Molecular,. http://www.sunsetmolecular.com/
141. Welcome to NetSci's List of Cheminformatics Databases,. http://www.netsci.org/Resources/Software/Cheminfo/databases.html
142. DrugBank,. http://www.drugbank.ca/
143. Wishart D. S., Knox C., Guo A. C., Shrivastava S., Hassanali M., Stothard P., Chang Z., Woolsey J., DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research 2006 34 D668 672 2-s2.0-33644876210
144. Oh B., Um C. H., Lee M. K., Bae H., Hong M. C., Shin M. K., Kim Y. S., THINKherb: the Herb INformation Knowledge base-the chip content database for herbal medicine. Biochip Journal 2009 2 4 274 279 2-s2.0-70449126778
145. Traditional Chinese medicine information database. http://tcm.cz3.nus. edu.sg/group/tcm-id/tcmid-ns.asp
146. Chen X., Zhou H., Liu Y. B., Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation. British Journal of Pharmacology 2006 149 8 1092 1103 (Pubitemid 44950812)
147. Traditional Chinese medicines integrated database,. http://www. megabionet.org/tcmid/
148. Xue R., Fang Z., Zhang M., Yi Z., Wen C., Shi T., TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Research 2013 41 1 D1089 D1095 10.1093/nar/gks1100
149. Vetrivel U., Subramanian N., Pilla K., InPACdb-Indian plant anticancer compounds database. Bioinformation 2009 4 2 71 74. http://www.inpacdb.org/ 10.6026/97320630004071
150. Gao Z., Li H., Zhang H., Liu X., Kang L., Luo X., Zhu W., Chen K., Wang X., Jiang H., PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008 9, article 104 2-s2.0-40549130652 10.1186/1471-2105-9-104 (Pubitemid 351356783)
151. Russ A. P., Lampel S., The druggable genome: an update. Drug Discovery Today 2005 10 23-24 1607 1610 2-s2.0-29144531173 10.1016/S1359-6446(05)03666-4 (Pubitemid 41817609)
152. Boran A. D. W., Iyengar R., Systems approaches to polypharmacology and drug discovery. Current Opinion in Drug Discovery and Development 2010 13 3 297 309 2-s2.0-77954052283
153. Overington J. P., Al-Lazikani B., Hopkins A. L., How many drug targets are there? Nature Reviews Drug Discovery 2006 5 12 993 996 2-s2.0-33751547539 10.1038/nrd2199 (Pubitemid 44835126)
154. Ioannidis J. P. A., Panagiotou O. A., Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. Journal of the American Medical Association 2011 305 21 2200 2210 2-s2.0-79957789708 10.1001/jama.2011.713
155. Smith S. R., Metabolic syndrome targets. Current Drug Targets-CNS & Neurological Disorders 2004 3 5 431 439 2-s2.0-9144256203 10.2174/ 1568007043337030 (Pubitemid 39545299)
156. Brown L., Targets of research in the metabolic syndrome. Endocrine, Metabolic and Immune Disorders 2011 11 3 181 2-s2.0-79961040230
157. Witt O., Deubzer H. E., Milde T., Oehme I., HDAC family: what are the cancer relevant targets? Cancer Letters 2009 277 1 8 21 2-s2.0-61849144810 10.1016/j.canlet.2008.08.016
158. Butler M. G., Genetics of hypertension. Current status. The Lebanese Medical Journal 2010 58 3 175 178 2-s2.0-79957669512
159. Machado-Vieira R., Salvadore G., DiazGranados N., Ibrahim L., Latov D., Wheeler-Castillo C., Baumann J., Henter I. D., Zarate C. A., New therapeutic targets for mood disorders. TheScientificWorldJournal 2010 10 713 726 2-s2.0-77952946669 10.1100/tsw.2010.65
160. Heim C., Nemeroff C. B., Neurobiology of posttraumatic stress disorder. CNS Spectrums 2009 14 1 13 24 2-s2.0-62449175735
161. Kim D. H., Stahl S. M., Antipsychotic drug development. Current topics in Behavioral Neurosciences 2010 4 123 139 2-s2.0-79952272122 10.1007/7854-2010-47
162. Asai M., Iwata N., Tomita T., Iwatsubo T., Ishiura S., Saido T. C., Maruyama K., Efficient four-drug cocktail therapy targeting amyloid- β peptide for Alzheimer's disease. Journal of Neuroscience Research 2010 88 16 3588 3597 2-s2.0-78049436194 10.1002/jnr.22503
163. Ruiz-Romero C., Blanco F. J., The role of proteomics in osteoarthritis pathogenesis research. Current Drug Targets 2009 10 6 543 556 2-s2.0-68349144328 10.2174/138945009788488404
164. Earl P. L., Cotter C., Moss B., VanCott T., Currier J., Eller L. A., McCutchan F., Birx D. L., Michael N. L., Marovich M. A., Robb M., Cox J. H., Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines. Vaccine 2009 27 42 5885 5895 2-s2.0-69749126408 10.1016/j.vaccine.2009.07.039
165. Borsook D., Becerra L., Hargreaves R., Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions. Discovery Medicine 2011 11 58 197 207 2-s2.0-79960149270
166. Saonere J. A., Antisense therapy, a magic bullet for the treatment of various diseases: present and future prospects. Journal of Medical Genetics and Genomics 2011 3 5 77 83
167. Transient ischemic attack. http://medical-dictionary.thefreedictionary. com/Transient+ischaemic+episode
168. O'Collins V. E., Macleod M. R., Donnan G. A., Horky L. L., van der Worp B. H., Howells D. W., 1,026 Experimental treatments in acute stroke. Annals of Neurology 2006 59 3 467 477 2-s2.0-33644818304 10.1002/ana.20741 (Pubitemid 43358067)
169. D'Onofrio P. M., Thayapararajah M., Lysko M. D., Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A. Journal of Neurotrauma 2011 28 9 1863 1879 10.1089/neu.2011.1896
170. van der Worp H. B., Sena E. S., Donnan G. A., Howells D. W., Macleod M. R., Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 2007 130 12 3063 3074 2-s2.0-34548491610 10.1093/brain/awm083 (Pubitemid 350209058)
171. Miyazawa T., Tamura A., Fukui S., Hossmann K. A., Effect of mild hypothermia on focal cerebral ischemia. Review of experimental studies. Neurological Research 2003 25 5 457 464 2-s2.0-0038164863 10.1179/ 016164103101201850 (Pubitemid 36870526)
172. den Hertog H. M., van der Worp H. B., Tseng M. C., Dippel D. W., Cooling therapy for acute stroke. Cochrane Database of Systematic Reviews 2009 1 CD001247 2-s2.0-62449096060
173. Xie L., Li J., Xie L., Bourne P. E., Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Computational Biology 2009 5 5 2-s2.0-67049100457 10.1371/journal.pcbi.1000387 e1000387
174. Zhou H., Beevers C. S., Huang S., The targets of curcumin. Current Drug Targets 2011 12 3 332 347 2-s2.0-79551618617
175. Wilhelm S. M., Adnane L., Newell P., Villanueva A., Llovet J. M., Lynch M., Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Molecular Cancer Therapeutics 2008 7 10 3129 3140 2-s2.0-55749088393 10.1158/1535-7163.MCT-08- 0013
176. Mestres J., Gregori-Puigjané E., Valverde S., Solé R. V., Data completeness-the achilles heel of drug-target networks. Nature Biotechnology 2008 26 9 983 984 2-s2.0-51349085387 10.1038/nbt0908-983
177. New drug failure rates rising in Phase II and III clinical trials. http://www.medcitynews.com/2011/06/new-drug-failure-rates-rising-in-phase-ii- and-iii-clinical-trials/
178. Birmingham A., Anderson E. M., Reynolds A., 3'UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nature Methods 2006 3 3 199 204 10.1038/nmeth854
179. Drawz S. M., Bonomo R. A., Three decades of β -lactamase inhibitors. Clinical Microbiology Reviews 2010 23 1 160 201 2-s2.0-74249108028 10.1128/CMR.00037-09
180. Warning over threat posed by new superbugs resistant to "last resort" antibiotics. http://teotwawki.ws/?p=948
181. Are you taking antibiotics without knowing it? http://www.consumer- health.com/services/cons-take66.php
182. Berger S. I., Iyengar R., Network analyses in systems pharmacology. Bioinformatics 2009 25 19 2466 2472 2-s2.0-70349847876 10.1093/bioinformatics/ btp465
183. Hormozdiari F., Berenbrink P., Przulj N., Sahinalp S. C., Not all scale-free networks are born equal: the role of the seed graph in PPI network evolution. PLoS Computational Biology 2007 3 7, article e118 2-s2.0-48049111636 10.1371/journal.pcbi.0030118 (Pubitemid 47196177)
184. Forde K. A., Reddy K. R., Hepatitis C Virus Infection and Immunomodulatory Therapies. Clinics in Liver Disease 2009 13 3 391 401 2-s2.0-67650523019 10.1016/j.cld.2009.05.007
185. Athyros V. G., Tziomalos K., Karagiannis A., Mikhailidis D. P., Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. The Open Cardiovascular Medicine Journal 2011 5 24 34
186. Wu P. F., Zhang Z., Wang F., Chen J. G., Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury. Acta Pharmacologica Sinica 2010 31 12 1523 1531 2-s2.0-78649947576 10.1038/aps.2010.186
187. NIH news release,. http://www.nih.gov/news/pr/jun2000/nhgri-26.htm
188. Galeazzi R., Molecular dynamics as a tool in rational drug design: current status and some major applications. Current Computer-Aided Drug Design 2009 5 4 225 240 2-s2.0-73449141827 10.2174/157340909789577847
189. de Vivo M., Bridging quantum mechanics and structure-based drug design. Frontiers in Bioscience 2011 16 5 1619 1633 2-s2.0-79955045990 10.2741/3809
190. Raha K., Peters M. B., Wang B., The role of quantum mechanics in structure-based drug design. Drug Discovery Today 2007 12 17-18 725 731 10.1016/j.drudis.2007.07.006 (Pubitemid 47364833)
191. Zhou S. F., Zhou Z. W., Li C. G., Chen X., Yu X., Xue C. C., Herington A., Identification of drugs that interact with herbs in drug development. Drug Discovery Today 2007 12 15-16 664 673 2-s2.0-34547733497 10.1016/j.drudis.2007. 06.004 (Pubitemid 47238642)
192. Cragg G. M., Newman D. J., International collaboration in drug discovery and development from natural sources. Pure and Applied Chemistry 2005 77 11 1923 1942 2-s2.0-28544433237 10.1351/pac200577111923 (Pubitemid 41746295)
193. Gene expression profiling-Chinese medicine functional genomics research Reflec. http://www.biosino.org/news-2002/200203/02031507.htm
194. van der Hoorn J. W. A., Jukema J. W., Havekes L. M., Lundholm E., Camejo G., Rensen P. C. N., Princen H. M. G., The dual PPAR α / γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE3Leiden.CETP transgenic mice. British Journal of Pharmacology 2009 156 7 1067 1075 2-s2.0-67650698528 10.1111/j.1476-5381.2008.00109.x
195. Balazs R., Vernon J., Hardy J., Epigenetic mechanisms in Alzheimer's disease: progress but much to do. Neurobiology of Aging 2011 32 7 1181 1187 2-s2.0-79958763443 10.1016/j.neurobiolaging.2011.02.024
196. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J. C., Carrasquillo M. M., Abraham R., Hamshere M. L., Pahwa J. S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M. K., Brayne C., Rubinsztein D. C., Gill M., Lawlor B., Lynch A., Brown K. S., Passmore P. A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A. D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P. G., Hooper N. M., Vardy E. R. L. C., Hardy J., Mead S., Fox N. C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A. M., Kauwe J. S. K., Cruchaga C., Nowotny P., Morris J. C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P. P., van Broeckhoven C., Livingston G., Bass N. J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C. E., Tsolaki M., Singleton A. B., Guerreiro R., Mühleisen T. W., Nöthen M. M., Moebus S., Jöckel K. H., Klopp N., Wichmann H. E., Pankratz V. S., Sando S. B., Aasly J. O., Barcikowska M., Wszolek Z. K., Dickson D. W., Graff-Radford N. R., Petersen R. C., van Duijn C. M., Breteler M. M. B., Ikram M. A., Destefano A. L., Fitzpatrick A. L., Lopez O., Launer L. J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J. F., Tzourio C., Alpérovitch A., Lathrop M., Feulner T. M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., SnÆdal J., Björnsson S., Jonsson P. V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M. J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P. A., Jonsson T., Riemenschneider M., Morgan K., Younkin S. G., Owen M. J., O'Donovan M., Amouyel P., Williams J., Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics 2011 43 5 429 436 2-s2.0-79955484414 10.1038/ng.803
197. Naj A. C., Jun G., Beecham G. W., Wang L. S., Vardarajan B. N., Buros J., Gallins P. J., Buxbaum J. D., Jarvik G. P., Crane P. K., Larson E. B., Bird T. D., Boeve B. F., Graff-Radford N. R., De Jager P. L., Evans D., Schneider J. A., Carrasquillo M. M., Ertekin-Taner N., Younkin S. G., Cruchaga C., Kauwe J. S. K., Nowotny P., Kramer P., Hardy J., Huentelman M. J., Myers A. J., Barmada M. M., Demirci F. Y., Baldwin C. T., Green R. C., Rogaeva E., George-Hyslop P. S., Arnold S. E., Barber R., Beach T., Bigio E. H., Bowen J. D., Boxer A., Burke J. R., Cairns N. J., Carlson C. S., Carney R. M., Carroll S. L., Chui H. C., Clark D. G., Corneveaux J., Cotman C. W., Cummings J. L., Decarli C., Dekosky S. T., Diaz-Arrastia R., Dick M., Dickson D. W., Ellis W. G., Faber K. M., Fallon K. B., Farlow M. R., Ferris S., Frosch M. P., Galasko D. R., Ganguli M., Gearing M., Geschwind D. H., Ghetti B., Gilbert J. R., Gilman S., Giordani B., Glass J. D., Growdon J. H., Hamilton R. L., Harrell L. E., Head E., Honig L. S., Hulette C. M., Hyman B. T., Jicha G. A., Jin L. W., Johnson N., Karlawish J., Karydas A., Kaye J. A., Kim R., Koo E. H., Kowall N. W., Lah J. J., Levey A. I., Lieberman A. P., Lopez O. L., MacK W. J., Marson D. C., Martiniuk F., Mash D. C., Masliah E., McCormick W. C., McCurry S. M., McDavid A. N., McKee A. C., Mesulam M., Miller B. L., Miller C. A., Miller J. W., Parisi J. E., Perl D. P., Peskind E., Petersen R. C., Poon W. W., Quinn J. F., Rajbhandary R. A., Raskind M., Reisberg B., Ringman J. M., Roberson E. D., Rosenberg R. N., Sano M., Schneider L. S., Seeley W., Shelanski M. L., Slifer M. A., Smith C. D., Sonnen J. A., Spina S., Stern R. A., Tanzi R. E., Trojanowski J. Q., Troncoso J. C., van Deerlin V. M., Vinters H. V., Vonsattel J. P., Weintraub S., Welsh-Bohmer K. A., Williamson J., Woltjer R. L., Cantwell L. B., Dombroski B. A., Beekly D., Lunetta K. L., Martin E. R., Kamboh M. I., Saykin A. J., Reiman E. M., Bennett D. A., Morris J. C., Montine T. J., Goate A. M., Blacker D., Tsuang D. W., Hakonarson H., Kukull W. A., Foroud T. M., Haines J. L., Mayeux R., Pericak-Vance M. A., Farrer L. A., Schellenberg G. D., Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics 2011 43 5 436 441 2-s2.0-79955464911 10.1038/ng.801
198. Desilets A. R., Gickas J. J., Dunican K. C., Role of huperzine A in the treatment of alzheimer's disease. The Annals of Pharmacotherapy 2009 43 3 514 518 2-s2.0-62949139899 10.1345/aph.1L402
199. Li J., Wu H. M., Zhou R. L., Liu G. J., Dong B. R., Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews 2008 2 CD005592 2-s2.0-44949092629
200. Little J. T., Walsh S., Aisen P. S., An update on huperzine A as a treatment for Alzheimer's disease. Expert Opinion on Investigational Drugs 2008 17 2 209 215 2-s2.0-39049152973 10.1517/13543784.17.2.209 (Pubitemid 351578201)
201. Zhang H. Y., Zheng C. Y., Yan H., Wang Z. F., Tang L. L., Gao X., Tang X. C., Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. Chemico-Biological Interactions 2008 175 1-3 396 402 2-s2.0-50649111381 10.1016/j.cbi.2008.04.049
202. Zhang H. Y., Yan H., Tang X. C., Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. Cellular and Molecular Neurobiology 2008 28 2 173 183 2-s2.0-39149123780 10.1007/s10571-007-9163-z (Pubitemid 351253069)
203. One thousand kinds of animals and plants Genome Project. http://news.sciencenet.cn/htmlnews/2010/5/232132.shtm
204. China has successfully developed the world's first medicinal plant genome framework map. http://news.sciencenet.cn/htmlnews/2010/6/233548.shtm
205. Liu B., Wang H., Du Z., Li G., Ye H., Metabolic engineering of artemisinin biosynthesis in Artemisia annua L. Plant Cell Reports 2011 30 5 689 694 2-s2.0-79954595318 10.1007/s00299-010-0967-9
206. Liu C., Zhao Y., Wang Y., Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug. Applied Microbiology and Biotechnology 2006 72 1 11 20 2-s2.0-33747138408 10.1007/s00253-006-0452-0 (Pubitemid 44222418)
207. Ro D. K., Paradise E. M., Quellet M., Fisher K. J., Newman K. L., Ndungu J. M., Ho K. A., Eachus R. A., Ham T. S., Kirby J., Chang M. C. Y., Withers S. T., Shiba Y., Sarpong R., Keasling J. D., Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006 440 7086 940 943 2-s2.0-33645870422 10.1038/nature04640
208. Lenihan J. R., Tsuruta H., Diola D., Renninger N. S., Regentin R., Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies. Biotechnology Progress 2008 24 5 1026 1032 2-s2.0-56249130054 10.1002/btpr.27
209. The human genome project,. http://www.essortment.com/human-genome- project-59573.html
210. Cragg G. M., Newman D. J., Nature: a vital source of leads for anticancer drug development. Phytochemistry Reviews 2009 8 2 313 331 2-s2.0-67651146398 10.1007/s11101-009-9123-y
211. Mice, men share 99 percent of genes. http://edition.cnn.com/2002/TECH/ science/12/04/coolsc.coolsc.mousegenome/
212. Culliton B. J., The humanized fly. http://www.barbaraculliton.com/ humanized-fly.pdf
213. Napoli C., Lemieux C., Jorgensen R., Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. The Plant Cell 1990 2 4 279 289 2-s2.0-0001359591 (Pubitemid 120029588)
214. Zhao Z., Liang Z., Chan K., Lu G., Lee E. L. M., Chen H., Li L., A unique issue in the standardization of Chinese materia medica: processing. Planta Medica 2010 76 17 1975 1986 2-s2.0-78649918891 10.1055/s-0030-1250522
215. Liao F., Discovery of artemisinin (Qinghaosu). Molecules 2009 14 12 5362 5366 2-s2.0-73849093637 10.3390/molecules14125362
216. Process of artemisinin discovery. http://blog.sciencenet.cn/home.php?mod= space&uid=396469&do=blog&id=365064
217. Ecological ethics. http://stats.oecd.org/glossary/detail.asp?ID=716
218. Singh J. S., The biodiversity crisis: a multifaceted review. Current Science 2002 82 638 647 (Pubitemid 135698157)
219. Please don't ask us to carry these herbs,. http://www.frontiercoop.com/ learn/herbs.php
220. Protection of endangered CHM. http://www.zhong-yao.net/ys/cc/200802/ 90460.html
221. Chinese herbal medicinal decoding. http://it.oyksoft.com/post/2505
222. Li L. Y., Ciren B. Z., Zhan D., Wei Y. F., Comprehensive utilization and development of traditional Tibetan medicine in China China Journal of Chinese Materia Medica 2001 26 12 808 810 2-s2.0-0142009482
223. Huang L., Yang B., Wang M., Fu G., An approach to some problems on utilization of medicinal plant resource in China China Journal of Chinese Materia Medica 1999 24 2 70 73 2-s2.0-0033068428
224. Endangered wild plants in Chinese Herbal Medicine. http://www.zhong-yao. net/zy/sc/zy/200803/107540.html
225. Azaizeh H., Saad B., Khalil K., Said O., The state of the art of traditional Arab herbal medicine in the Eastern region of the Mediterranean: a review. Evidence-based Complementary and Alternative Medicine 2006 3 2 229 235 2-s2.0-33745712171 10.1093/ecam/nel034
226. Marson P., Pasero G., The Italian contributions to the history of salicylates Reumatismo 2006 58 1 66 75 2-s2.0-33746515510 (Pubitemid 46785289)
227. Mahdi J. G., Mahdi A. J., Mahdi A. J., Bowen I. D., The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Proliferation 2006 39 2 147 155 2-s2.0-33644954675 10.1111/j.1365-2184.2006.00377.x
228. Zhao K. C., Song Z. Y., Pharmacokinetics of dihydroqinghaosu in human volunteers and comparison with qinghaosu Acta Pharmaceutica Sinica 1993 28 5 342 346 2-s2.0-0009812974
229. Li Q. G., Peggins J. O., Fleckenstein L. L., Masonic K., Heiffer M. H., Brewer T. G., The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. The Journal of Pharmacy and Pharmacology 1998 50 2 173 182 2-s2.0-0031911977 (Pubitemid 28102574)
230. Progress in standardized planting of Chinese herbal medicines. http://www.med66.com/new/56a294a2010/201047qiji112120.shtml
231. Medicinal plants. www.hm160.cn/121/1211108.htm
232. Zhang B., Peng Y., Zhang Z., Liu H., Qi Y., Liu S., Xiao P., GAP production of TCM herbs in China. Planta Medica 2010 76 17 1948 1955 2-s2.0-78649903606 10.1055/s-0030-1250527
233. Heuberger H., Bauer R., Friedl F., Heubl G., Hummelsberger J., Nögel R., Seidenberger R., Torres-Londoño P., Cultivation and breeding of Chinese medicinal plants in Germany. Planta Medica 2010 76 17 1956 1962 2-s2.0-78649904719 10.1055/s-0030-1250528
234. Zhang L., Jing F., Li F., Li M., Wang Y., Wang G., Sun X., Tang K., Development of transgenic Artemisia annua (Chinese worm-wood) plants with an enhanced content of artemisinin, an effective anti-malarial drug, by hairpin-RNA-mediated gene silencing. Biotechnology and Applied Biochemistry 2009 52 3 199 207 2-s2.0-67349227971 10.1042/BA20080068
235. Baldi A., Dixit V. K., Yield enhancement strategies for artemisinin production by suspension cultures of Artemisia annua. Bioresource Technology 2008 99 11 4609 4614 2-s2.0-41849126781 10.1016/j.biortech.2007.06.061 (Pubitemid 351503806)
236. Newman J. D., Marshall J., Chang M., Nowroozi F., Paradise E., Pitera D., Newman K. L., Keasling J. D., High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnology and Bioengineering 2006 95 4 684 691 2-s2.0-33750557880 10.1002/bit.21017 (Pubitemid 44671470)
237. Wang J. H., Lia W., Sha Y., Tezuka Y., Kadota S., Li X., Triterpenoid saponins from leaves and stems of Panax quinquefolium L. Journal of Asian Natural Products Research 2001 3 2 123 130 2-s2.0-0035719626 (Pubitemid 34184771)
238. Chen J., Zhao R., Zeng Y. M., Meng H., Zuo W. J., Li X., Wang J. H., Three new triterpenoid saponins from the leaves and stems of Panax quinquefolium. Journal of Asian Natural Products Research 2009 11 3 195 201 2-s2.0-65649094009 10.1080/10286020802682734
239. Gurib-Fakim A., Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006 27 1 1 93 2-s2.0-29044445562 10.1016/j.mam.2005.07.008 (Pubitemid 41790645)